Atlas Trials

Safety and Efficacy Study of Ftortiazinon in the Treatment of Patients With Complicated Urinary Tract Infections Caused by P. Aeruginosa

Clinical trial NCT03638830 · COMPLETED

Trial details

NCT number
NCT03638830
Sponsor
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Patients With Complicated Urinary Tract Infections Caused by P. AeruginosaPseudomonas AeruginosaPseudomonas InfectionsUrinary Tract Infections
Start date
2018-10-17
Primary completion
2022-11-23
Enrollment
777

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.